Bacterial infections in patients with type 1 diabetes: A 14-year follow-up study

BMJ Open Diabetes Research and Care

Volumn 3, Issue 1, 2015, Pages

  Simonsen, Johan R ^a,b,c   Harjutsalo, Valma ^a,b,c,d   Järvinen, Asko ^b   Kirveskari, Juha ^b   Forsblom, Carol ^a,b,c   Groop, Per Henrik ^a,b,c,e   Lehto, Markku ^a,b,c  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; END STAGE RENAL DISEASE; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; UROGENITAL SYSTEM PARAMETERS;

EID: 85032682416     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2014-000067     Document Type: Article

References (29)

1. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-13.
2. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 2001;24:1044-9.
3. Seshasai SR, Kaptoge S, Thompson A, et al., The Emerging Risk Factor Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41.
4. Thomsen RW, Hundborg HH, Lervang HH, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care 2004;27:1143-7.
5. Thomsen RW, Hundborg HH, Lervang HH, et al. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteremia: a 10-year population based study among adults. Clin Infect Dis 2005;40:628-31.
6. Thomsen RW, Riis AH, Kjeldsen S, et al. Impact of diabetes and poor glycaemic control on risk of bacteremia with haemolytic streptococci groups A, B, and G. J Infect 2011;63:8-16.
7. Valerius NH, Eff C, Hansen NE, et al. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 1982;211:463-7.
8. Marhoffer W, Stein M, Maeser E, et al. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256-60.
9. Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997;14:29-34.
10. Muller LMAJ, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-8.
11. Gordin D, Forsblom C, Rönnback M, et al. Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Ann Med 2008;40:627-33.
12. Cherney DZ, Scholey JW, Sochett E, et al. The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care 2011;34:177-80.
13. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalization and outcome. Diabetologia 2007;50:549-54.
14. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.
15. Kim PJ, Steinberg JS. Complications of the diabetic foot. Endocrinol Metab Clin North Am 2013;42:833-47.
16. Choncol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006;19:291-6.
17. Wang HE, Gamboa C, Warnock DG, et al. Chronic kidney disease and risk of death from infection. Am J Nephrol 2011;34:330-6.
18. James MT, Laupland KB, Tonelli M, et al. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 2008;168:2333-9.
19. Saraheimo M, Teppo AM, Forsblom C, et al. Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 2003;46:1402-7.
20. Fornoni A, Ijaz A, Tejada T, et al. Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 2008;4:10-17.
21. Min Y, Agresti A. Random effect models for repeated measures of zero-inflated count data. Stat Model 2005;5:1-19.
22. Hamilton EJ, Martin N, Makepeace A, et al. Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the Fremantle diabetes study. PLoS ONE 2013;8:e60502.
23. Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol 2009;15:4137-42.
24. Kornum JB, Thomsen RW, Riis A, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population based case-control study. Diabetes Care 2008;31:1541-5.
25. Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001;24:131-53.
26. Boyanova L, Mitov I. Antibiotic rates in causative agents of infections in diabetic patients: rising concerns. Expert Rev Anti Infect Ther 2013;11:411-20.
27. Fimea; Lääkekulutus vuosina 2009-2012. http://raportit.nam.fi/ raportit/kulutus/laakekulutus.htm (accessed 12 Apr 2014).
28. Doi K, Leelahavanichkul A, Yuen PS, et al. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009;119:2868-78.
29. Nymark M, Pussinen PJ, Tuomainen AM, et al. Serum lipopolysaccharide activity is associated with the progression of kidney disease in Finnish patients with type 1 diabetes. Diabetes Care 2009;32:1689-93.